Urinary, bowel and sexual health in older men from Northern Ireland

BJU International
David DonnellyA Gavin

Abstract

To provide data on the prevalence of urinary, bowel and sexual dysfunction in Northern Ireland (NI), to act as a baseline for studies of prostate cancer outcomes and to aid service provision within the general population. A cross-sectional postal survey of 10 000 men aged ≥40 years in NI was conducted and age-matched to the distribution of men living with prostate cancer. The EuroQoL five Dimensions five Levels (EQ-5D-5L) and 26-item Expanded Prostate Cancer Composite (EPIC-26) instruments were used to enable comparisons with prostate cancer outcome studies. Whilst representative of the prostate cancer survivor population, the age-distribution of the sample differs from the general population, thus data were generalised to the NI population by excluding those aged 40-59 years and applying survey weights. Results are presented as proportions reporting problems along with mean composite scores, with differences by respondent characteristics assessed using chi-squared tests, analysis of variance, and multivariable log-linear regression. Amongst men aged ≥60 years, 32.8% reported sexual dysfunction, 9.3% urinary dysfunction, and 6.5% bowel dysfunction. In all, 38.1% reported at least one problem and 2.1% all three. Worse outcome wa...Continue Reading

References

Mar 13, 2002·Gut·S PerryUNKNOWN Leicestershire MRC Incontinence Study Team
Feb 9, 2006·Scandinavian Journal of Primary Health Care·Doreth TeunissenToine Lagro-Janssen
Jul 25, 2007·The Journal of Sexual Medicine·Kew-Kim ChewKonrad Jamrozik
Feb 12, 2008·BJU International·Edson D MoreiraUNKNOWN GSSAB Investigators' Group
Feb 27, 2009·International Journal of Impotence Research·E O LaumannUNKNOWN GSSAB Investigators' Group
May 5, 2009·Gastroenterology·William E WhiteheadUNKNOWN Pelvic Floor Disorders Network
Apr 12, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M HerdmanX Badia
Jun 23, 2011·Family Practice·Eila K WatsonUNKNOWN Prostate Cancer Follow-Up Study Group
Sep 10, 2013·European Urology·Giorgio GandagliaCharalambos Vlachopoulos
Jun 26, 2014·BMJ : British Medical Journal·Jonathan ReesBen Challacombe
Dec 3, 2014·European Urology·Adam W Glaser, Jessica L Corner
Jan 28, 2015·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Katriina L WhitakerJane Wardle
Jul 2, 2015·European Urology·Alicia K MorgansUNKNOWN Advanced Prostate Cancer Working Group of the International Consortium for Health Outcomes Measurement
Oct 9, 2015·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Michael BauerDeirdre Fetherstonhaugh
Dec 4, 2016·International Journal of Colorectal Disease·Rob J MeindsPaul M A Broens
Jul 20, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·Y KouidratN Veronese

❮ Previous
Next ❯

Citations

Sep 18, 2018·International Journal of Clinical Practice·David W DonnellyAnna Gavin
Oct 26, 2018·BJU International·Julie A Szymaniak, Alexander P Cole
Jul 7, 2020·American Journal of Men's Health·Muhammad IrfanShaiful Bahari Ismail
Dec 23, 2020·Scandinavian Journal of Urology·Kari Vatne MonsenAndreas Stensvold

❮ Previous
Next ❯

Software Mentioned

EuroQoL
Statistical Package for the Social Sciences ( SPSS
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.